This study presents a rapid and low-cost method to detect thyroid dysfunction using serum Raman spectroscopy combined with support vector machine (SVM). The serum samples taken from 34 thyroid dysfunction patients and 40 healthy volunteers were measured in this study. Tentative assignments of the Raman bands in the measured serum spectra suggested specific biomolecular changes between the groups. Principal component analysis (PCA) was used for feature extraction and reduced the dimension of high-dimension spectral data; then, SVM was employed to establish an effective discriminant model. To improve the efficiency and accuracy of the SVM discriminant model, we proposed artificial fish coupled with uniform design (AFUD) algorithm to optimize the SVM parameters. The average accuracy of 30 discriminant results reached 82.74%, and the average optimization time was 0.45 s. The results demonstrate that the serum Raman spectroscopy technique combined with the AFUD-SVM discriminant model has great potential for the detection of thyroid dysfunction. This technique could be used to develop a portable, rapid, and low-cost device for detecting thyroid function to meet the needs of individuals and communities.
1 May 2019 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
In this study, we investigated the feasibility of using surface-enhanced Raman spectroscopy (SERS) combined with a support vector machine (SVM) algorithm to discriminate hysteromyoma and cervical cancer from healthy volunteers rapidly. SERS spectra of serum samples were recorded from 30 hysteromyoma patients, 36 cervical cancer patients as well as 30 healthy subjects. SVM was used to establish the classification models, and three types of kernel functions, namely linear, polynomial, and Gaussian radial basis function (RBF), were utilized for comparison. When the polynomial kernel function was employed, the overall diagnostic accuracy for classifying the three groups could achieve 86.5%. In addition, when the optimal kernel function was selected, the diagnostic accuracy for identifying healthy versus hysteromyoma, healthy versus cervical cancer, and hysteromyoma versus cervical cancer reached 98.3%, 93.9%, and 90.9%, respectively. The current results indicate that serum SERS technology, together with the SVM algorithm, is expected to become a clinical tool for rapid screening of hysteromyoma and cervical cancer.